Total cholesterol content of erythrocyte membranes in acute coronary syndrome: Correlation with apolipoprotein A-I and lipoprotein (a)

Coronary Artery Disease

Volumn 22, Issue 3, 2011, Pages 145-152

  Zhang, Jianhua ^a   Pan, Lingxin ^a   Xu, Yan ^a   Wu, Changhao ^b   Wang, Changhui ^a   Cheng, Ziping ^a   Zhao, Ren ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Acute coronary syndrome; apolipoprotein A I; lipoprotein (a); total cholesterol erythrocyte membranes

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; ERYTHROCYTE MEMBRANE; FEMALE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; APOLIPOPROTEIN A-I; CHOLESTEROL; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; STATISTICS AS TOPIC;

EID: 79955096199     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328343fbbb     Document Type: Article

References (44)

1. Seimiya K, Inami S, Takano M, Ohba T, Sakai S, Takano T, et al. Significance of plaque disruption sites in acute coronary syndrome. J Nippon Med Sch 2006; 73:141-148.
2. Tziakas DN, Kaski JC, Chalikias GK, Romero C, Fredericks S, Tentes IK, et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am Coll Cardiol 2007; 49:2081-2089. (Pubitemid 46771054)
3. Pasterkamp G, Virmani R. The erythrocyte: a new player in atheromatous core formation. Heart 2002; 88:115-116. (Pubitemid 34787753)
4. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996; 16:4-11. (Pubitemid 26026925)
5. Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985; 822:267-287. (Pubitemid 16196320)
6. Arbustini E, Morbini P, D'Armini AM, Repetto A, Minzioni G, Piovella F, et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002; 88:177-182. (Pubitemid 34787776)
7. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349:2316-2325. (Pubitemid 37509739)
8. Arbustini E. Total erythrocyte membrane cholesterol: an innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol 2007; 49:2090-2092.
9. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004; 110:2032-2038. (Pubitemid 39331918)
10. Kolodgie FD, Burke AP, Nakazawa G, Cheng Q, Xu X, Virmani R. Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol 2007; 18:500-507. (Pubitemid 47462201)
11. Yu MM, Xu Y, Zhang JH, Wang CH, Wang XC, Cheng ZP, et al. Total cholesterol content of erythrocyte membrane levels are associated with the presence of acute coronary syndrome and high-sensitivity C-reactive protein. Int J Cardiol 2010; 145:57-58.
12. Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Thomaidi A, Chatzikyriakou S, et al. Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes: a novel pleiotropic effect? Cardiovasc Drugs Ther 2009; 23:471-480.
13. Czarnecka H, Yokoyama S. Regulation of lecithin-cholesterol acyltransferase reaction by acyl acceptors and demonstration of its 'idling' reaction. J Biol Chem 1993; 268:19334-19340. (Pubitemid 23270707)
14. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, et al. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 2006; 48:2471-2481. (Pubitemid 44881216)
15. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969.
16. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001; 38:2114-2130. (Pubitemid 33116592)
17. Braunwald E. Unstable angina: a classification. Circulation 198; 80:410-414.
18. Arroyo-Espliguero R, Avanzas P, Cosin-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004; 25:401-408. (Pubitemid 38391522)
19. Tziakas DN, Chalikias GK, Tentes IK, Stakos D, Chatzikyriakou SV, Mitrousi K, et al. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. Eur Heart J 2008; 29:2713-2722.
20. Miwa S, Inouye M, Ohmura C, Mitsuhashi N, Onuma T, Kawamori R. Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients. Diabetes Res Clin Pract 2003; 61:81-88. (Pubitemid 37013651)
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509.
23. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475.
24. Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study. J Am Coll Cardiol 2009; 53:244-253.
25. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47:C13-C18.
26. Davies MJ. The composition of coronary artery plaques. N Engl J Med 1997; 336:1312-1314.
27. Lin HL, Xu XS, Lu HX, Li CJ, Tang MX, Sun HW, et al. Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques. Med Hypotheses 2008; 70:105-108.
28. Takaba M, Endo S, Kurimoto M, Kuwayama N, Nishijima M, Takaku A. Vasa vasorum of the intracranial arteries. Acta Neurochir (Wien) 1998; 140:411-416. (Pubitemid 28312784)
29. Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Papazoglou D, Thomaidi A, et al. Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation. Int J Cardiol 2010. doi:10.1016/j.ijcard.2010.02.022.
30. Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Chatzikyriakou SV, Mitrousi K, et al. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease. Coron Artery Dis 2008; 19:583-590.
31. Vayá A, Martínez Triguero M, Réganon E, Vila V, Martínez Sales V, Solá E, et al. Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin Hemorheol Microcirc 2008; 40:289-294.
32. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963; 59:369-382.
33. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein (a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies. Clin Chem 1998; 44:2301-2306. (Pubitemid 28511752)
34. Sawabe M, Tanaka N, Nakahara K, Hamamatsu A, Chida K, Arai T, et al. High lipoprotein (a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases. Heart 2009; 95:1997-2002.
35. Luc G, Bard JM, Arveiler D, Ferrieres J, Evans A, Amouyel P, et al. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME study. Atherosclerosis 2002; 163:377-384. (Pubitemid 34615830)
36. Stubbs P, Seed M, Lane D, Collinson P, Kendall F, Noble M. Lipoprotein (a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J 1998; 19:1355-1364. (Pubitemid 28427137)
37. Jaeger BR, Richter Y, Nagel D, Heigl F, Vogt A, Roeseler E, et al. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein (a) levels and prevent major adverse coronary events. Nat Clin Pract Cardiovasc Med 2009; 6:229-239.
38. Moore RE, Kawashiri MA, Kitajima K, Secreto A, Millar JS, Pratico D, et al. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler Thromb Vasc Biol 2003; 23:1914-1920. (Pubitemid 37254884)
39. Benoit P, Emmanuel F, Caillaud JM, Bassinet L, Castro G, Gallix P, et al. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models. Circulation 1999; 99:105-110. (Pubitemid 29035964)
40. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003; 290:2292-2300. (Pubitemid 37430562)
41. Barter P, Kastelein J, Nunn A, Hobbs R. High density lipoproteins (HDLs) and atherosclerosis: the unanswered questions. Atherosclerosis 2003; 168:195-211. (Pubitemid 36703318)
42. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36:211-228.
43. Bakogianni MC, Kalofoutis CA, Skenderi KI, Kalofoutis AT. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. J Diabetes Complications 2001; 15:265-269. (Pubitemid 32750615)
44. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56-62.